{"id":"https://openalex.org/W2891337534","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.10039","title":"Examining progression free survival (PFS), overall survival (OS), and toxicities of palbociclib in a geriatric population.","display_name":"Examining progression free survival (PFS), overall survival (OS), and toxicities of palbociclib in a geriatric population.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2891337534","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.10039","mag":"2891337534"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.10039","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.10039","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.10039","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081442263","display_name":"Katherine Clifton","orcid":"https://orcid.org/0000-0001-8623-995X","observed_orcids":["https://orcid.org/0000-0001-8623-995X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Clifton","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046839653","display_name":"Jaime Kimmel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaime Kimmel","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014713051","display_name":"Jennifer Keating Litton","orcid":"https://orcid.org/0000-0001-8390-4985","observed_orcids":["https://orcid.org/0000-0001-8390-4985"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Keating Litton","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110083321","display_name":"Debu Tripathy","orcid":"https://orcid.org/0000-0002-5711-2404","observed_orcids":["https://orcid.org/0000-0002-5711-2404"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debu Tripathy","raw_affiliation_strings":["Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009694312","display_name":"Meghan Sri Karuturi","orcid":"https://orcid.org/0000-0001-8795-3901","observed_orcids":["https://orcid.org/0000-0001-8795-3901"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meghan Sri Karuturi","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"10039","last_page":"10039"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9570000171661377},{"id":"https://openalex.org/keywords/geriatric-oncology","display_name":"geriatric oncology","score":0.8420000076293945},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.906000018119812},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.972000002861023},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.7820000052452087},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.902999997138977},{"id":"https://openalex.org/keywords/dose-delay","display_name":"dose delay","score":0.9639999866485596},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.6499999761581421},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.7239999771118164},{"id":"https://openalex.org/keywords/age-related-outcomes","display_name":"age-related outcomes","score":0.4300000071525574},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.7289999723434448},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.6589999794960022},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.5210000276565552},{"id":"https://openalex.org/keywords/patient-satisfaction","display_name":"patient satisfaction","score":0.3089999854564667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9350728988647461},{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.7830458879470825},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.622199535369873},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.605835497379303},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5582900643348694},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4880613088607788},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.43995577096939087},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39842313528060913},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3879203796386719},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.3239613175392151},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.19881460070610046},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.16206184029579163},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.10039","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.10039","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.10039","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2920014560","https://openalex.org/W7130684429","https://openalex.org/W4309287393","https://openalex.org/W4292600996","https://openalex.org/W4386474237","https://openalex.org/W3210627733","https://openalex.org/W3130652582","https://openalex.org/W2981869634","https://openalex.org/W4385424521","https://openalex.org/W4399456770"],"abstract_inverted_index":{"10039":[0],"Background:":[1],"A":[2],"recent":[3],"FDA":[4],"pooled":[5],"analysis":[6],"of":[7,50,72,85,92,185,269],"patients":[8],"treated":[9],"with":[10,76,335],"CDK4/6":[11],"inhibitors":[12],"showed":[13],"a":[14,65,90,181,248],"trend":[15],"towards":[16],"improved":[17,250,314],"PFS":[18,137,251],"in":[19,36,64,82,226,235,281,283,302,340],"the":[20,37,41,116,143,199,236,255,303,307,341],"geriatric":[21,38,66,304,308,342],"population,":[22,39],"although":[23],"this":[24,51],"was":[25,46,53,120,222,262,272,278,299,310],"not":[26],"statistically":[27],"significant.":[28],"The":[29,48,243],"study":[30,52],"found":[31,311],"more":[32],"grade":[33],"3-4":[34],"events":[35],"however":[40],"overall":[42],"adverse":[43],"event":[44],"rate":[45],"low.":[47],"objective":[49],"to":[54,198,254,312,320,328],"analyze":[55],"PFS,":[56],"OS,":[57],"dose":[58,60,108,186,192],"reductions,":[59,109],"delays":[61,193],"and":[62,101,110,129,138,170,191,213],"toxicity":[63,227],"population":[67,309],"receiving":[68,80,157],"palbociclib":[69,81,158,331],"as":[70,252],"standard":[71],"care.":[73],"Methods:":[74],"Patients":[75],"metastatic":[77],"breast":[78],"cancer":[79],"any":[83],"line":[84],"therapy":[86],"were":[87,104,112,140,154,162,166,173],"identified":[88],"from":[89,115],"cohort":[91,239,246,257,285],"845":[93],"pts":[94,149,165,172],"at":[95],"MDACC.":[96],"Clinical,":[97],"demographic,":[98],"comorbidities,":[99],"recurrence":[100],"survival":[102],"data":[103],"collected.":[105],"Dose":[106],"delays,":[107],"toxicities":[111],"retrospectively":[113],"extracted":[114],"medical":[117],"record.":[118],"Data":[119],"analyzed":[121,141],"using":[122,142],"Fischer's":[123],"exact":[124],"test":[125,133],"for":[126,134],"categorized":[127],"variables":[128],"T":[130],"test/Wilcoxon":[131],"rank-sum":[132],"continuous":[135],"variables.":[136],"OS":[139,282],"Kaplan":[144],"Meier":[145],"method.":[146],"Results:":[147],"605":[148],"who":[150],"met":[151],"eligibility":[152],"criteria":[153],"included.":[155],"Pts":[156,177,202],"on":[159],"clinical":[160],"trial":[161],"excluded.":[163],"160":[164],"\u2265":[167,174,178,203,237,244,270,292],"65":[168,271,293],"years-old":[169],"92":[171],"70":[175,179,204,238,245],"years-old.":[176],"had":[180,205,247],"significantly":[182,206,249],"increased":[183],"number":[184],"reductions":[187],"(p":[188,194,210,218,240,258,274],"=":[189,195,241,259,275,289,295],"0.03)":[190],"0.02)":[196],"compared":[197,253],"younger":[200,256],"pts.":[201],"lower":[207],"baseline":[208],"GFR":[209],"<":[211,219],"0.0001)":[212],"higher":[214],"Charleston":[215],"Comorbidity":[216],"index":[217],"0.0001).":[220],"There":[221,277],"no":[223,279],"significant":[224],"increase":[225],"rate,":[228],"including":[229],"neutropenic":[230],"fever,":[231],"infections,":[232],"or":[233],"hospitalizations,":[234],"0.3).":[242],"0.02).":[260],"This":[261],"also":[263],"true":[264],"when":[265],"an":[266],"age":[267,291],"cut-off":[268],"used":[273],"0.009).":[276],"difference":[280],"either":[284],"(age":[286],"\u226570":[287],"p":[288,294],"0.4,":[290],"0.9).":[296],"Conclusions:":[297],"Palbociclib":[298,316],"well":[300],"tolerated":[301],"population.":[305,343],"Interestingly,":[306],"have":[313],"PFS.":[315],"has":[317],"been":[318],"shown":[319],"restore":[321],"senescence":[322,338],"signaling.":[323],"Further":[324],"studies":[325],"are":[326],"warranted":[327],"investigate":[329],"if":[330],"may":[332],"work":[333],"synergistically":[334],"already":[336],"enhanced":[337],"pathways":[339]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2018-09-27T00:00:00"}